Isofol Medical AB (publ) (STO:ISOFOL)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.8805
-0.0260 (-2.87%)
Aug 1, 2025, 5:29 PM CET

Isofol Medical AB Company Description

Isofol Medical AB (publ) operates as a clinical stage biotech company.

The company develops arfolitixorin, which is in phase Ib/II clinical trial for the treatment of metastatic colorectal cancer.

Isofol Medical AB (publ) was incorporated in 2008 and is based in Gothenburg, Sweden.

Isofol Medical AB (publ)
Isofol Medical AB logo
CountrySweden
Founded2008
IndustryBiotechnology
SectorHealthcare
Employees5
CEOPetter Lindqvist

Contact Details

Address:
Biotech Center
Gothenburg, 413 46
Sweden
Phone46 0 31 13 73 31
Websiteisofolmedical.com

Stock Details

Ticker SymbolISOFOL
ExchangeNasdaq Stockholm
Fiscal YearJanuary - December
Reporting CurrencySEK
ISIN NumberSE0009581051
SIC Code2834

Key Executives

NamePosition
Petter Segelman LindqvistChief Executive Officer
Dr. Roger Tell M.D., Ph.D.Chief Medical Officer
Margareta Hagman M.B.A.Chief Financial Officer